Triad Life Sciences is a verifiably legitimate biotechnology entity (acquired by Convatec in 2022) with significant real-world utility in regenerative medicine. However, the project submission itself is of extremely low quality, containing hyperbolic and factually incorrect claims (e.g., 'most people have used my product', 'audience: everyone') and nonsensical data for revenue. While the underlying technology and business traction are exceptional (high acquisition value), the Proof of Usefulness score is heavily penalized by the lack of verifiable evidence provided in the submission and the vague, unprofessional responses.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline